Invited response to: Controlling the Cost of Management of Congenital Heart Disease

• Type of Material: Article
• Authors: Kimberly E. McHugh, Medical University of South Carolina; Sara K. Pasquali, University of Michigan; William Mahle, Emory University
• Language: English
• Date: 2020-03-01
• Publisher: ELSEVIER SCIENCE INC
• Publication Version: Author Accepted Manuscript (After Peer Review)
• Copyright Statement: © 2019 by The Society of Thoracic Surgeons Published by Elsevier
• License: Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1016/j.athoracsur.2019.09.054
• Title of Journal or Parent Work: ANNALS OF THORACIC SURGERY
• Volume: 109
• Issue: 3
• Start Page: 989
• End Page: 989
• Keywords: Science & Technology; Cardiovascular System & Cardiology; Cardiac & Cardiovascular Systems; Life Sciences & Biomedicine; Respiratory System; Surgery

Abstract

We appreciate the thoughtful response from Drs. Peer and Jonas1. The number of patients who previously underwent staged management of Tetralogy of Fallot (TOF) was not evaluated in this study2, as this is unlikely to influence the change in hospital costs following implementation of an early extubation clinical practice guideline.